BRCA1 and breast cancer: This mutation was selected for extended case-control analysis in independent BRCA1-mutated BC cases, which included 278 young-onset and 337 late-onset patients from Poland (“PUM” cohort) and Russia (“SPb” cohort) (Table 3).